Search results
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 10 hours agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
AbbVie Inc. (NYSE:ABBV) Shares Bought by Childress Capital Advisors LLC
ETF DAILY NEWS· 12 hours agoChildress Capital Advisors LLC raised its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.8% during the fourth quarter, according to the company in its most recent ...
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 11 hours agoAbbVie is securing its place in an emerging gastrointestinal disease drug field, paying China-based FutureGen Biopharmaceutical $150 million in immediate...
Sanibel Captiva Trust Company Inc. Invests $41.99 Million in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 11 hours agoSanibel Captiva Trust Company Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure ...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 15 hours agoAbbVie has made a licence agreement with FutureGen Biopharmaceutical to develop a next-generation...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 1 day agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
Benzinga via Yahoo Finance· 1 day agoWith 52 consecutive years of dividend growth and a dividend yield of over 3.6%, AbbVie Inc....
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
AbbVie joins TL1A race via $150M upfront deal with China's FutureGen
FierceBiotech· 1 day agoAbbVie has become the latest Big Pharma to jump on the anti-TL1A train, paying China’s FutureGen Biopharmaceutical $150 million upfront for a preclinical inflammatory bowel ...
AbbVie Inc. (NYSE:ABBV) Holdings Lowered by Westwood Holdings Group Inc.
ETF DAILY NEWS· 5 days agoWestwood Holdings Group Inc. lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the fourth quarter, Holdings Channel.com reports. The fund ...
